{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "SATSUMA PHARMACEUTICALS", "longName": "Satsuma Pharmaceuticals, Inc.", "messageBoardId": "finmb_414654964", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 1.5789459, "regularMarketPrice": 0.965, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1581922800000, "priceHint": 4, "epsTrailingTwelveMonths": -2.04, "epsForward": -1.73, "epsCurrentYear": -1.94, "priceEpsCurrentYear": -0.49742267, "sharesOutstanding": 33152500, "bookValue": 1.412, "fiftyDayAverage": 0.8377, "fiftyDayAverageChange": 0.12729996, "fiftyDayAverageChangePercent": 0.15196367, "twoHundredDayAverage": 2.72655, "twoHundredDayAverageChange": -1.7615502, "twoHundredDayAverageChangePercent": -0.6460729, "marketCap": 32351046, "forwardPE": -0.55780345, "priceToBook": 0.68342775, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.2 - Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 0.014999986, "regularMarketTime": 1683871252, "regularMarketDayHigh": 0.965, "regularMarketDayRange": "0.965 - 0.965", "regularMarketDayLow": 0.965, "regularMarketVolume": 1600, "regularMarketPreviousClose": 0.95, "bid": 0.97, "ask": 0.985, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 0.965, "averageDailyVolume3Month": 89, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.38, "fiftyTwoWeekLowChangePercent": 0.6495727, "fiftyTwoWeekRange": "0.585 - 8.05", "fiftyTwoWeekHighChange": -7.085, "fiftyTwoWeekHighChangePercent": -0.8801242, "fiftyTwoWeekLow": 0.585, "fiftyTwoWeekHigh": 8.05, "earningsTimestamp": 1683835200, "earningsTimestampStart": 1691438700, "earningsTimestampEnd": 1691784300, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "1LV.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "400 Oyster Point Boulevard", "address2": "Suite 221", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 410 3200", "website": "https://www.satsumarx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Satsuma Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops novel therapeutic products for the acute treatment of migraines. The company's product candidature includes STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 25, "companyOfficers": [{"maxAge": 1, "name": "Mr. John A. Kollins MBA", "age": 59, "title": "Pres, CEO & Director", "yearBorn": 1963, "fiscalYear": 2021, "totalPay": {"raw": 830000, "fmt": "830k", "longFmt": "830,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 759256, "fmt": "759.26k", "longFmt": "759,256"}}, {"maxAge": 1, "name": "Mr. Thomas P. O'Neil", "age": 57, "title": "Chief Financial Officer", "yearBorn": 1965, "fiscalYear": 2021, "totalPay": {"raw": 550080, "fmt": "550.08k", "longFmt": "550,080"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 185923, "fmt": "185.92k", "longFmt": "185,923"}}, {"maxAge": 1, "name": "Dr. Detlef F. Albrecht", "age": 61, "title": "Chief Medical Officer", "yearBorn": 1961, "fiscalYear": 2021, "totalPay": {"raw": 625968, "fmt": "625.97k", "longFmt": "625,968"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 290571, "fmt": "290.57k", "longFmt": "290,571"}}, {"maxAge": 1, "name": "Mr. Mic  Iwashima", "age": 44, "title": "VP & Head of Operations", "yearBorn": 1978, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Robert  Schultz", "age": 58, "title": "Sr. VP & Head of Chemistry, Manufacturing and Controls", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Shannon  Strom Ph.D.", "age": 46, "title": "VP & Head of Regulatory Affairs", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Robert M. Janosky", "title": "Chief Commercial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}